Discontinuities in atypical antipsychotic therapy following prior authorization and step therapy among medicaid beneficiaries with schizophrenia

被引:0
|
作者
Soumerai, S. B. [1 ]
Zhang, F. [1 ]
Ross-Degnan, D. [1 ]
Ball, D. E. [2 ]
Lecates, R. F. [1 ]
Law, M. R. [1 ]
Hughes, T. E. [2 ]
Chapman, D. [3 ]
Adams, A. S. [1 ]
机构
[1] Harvard Med Sch & Harvard Pilgrim Hlth Care, Boston, MA USA
[2] Eli Lilly & Co, Indianapolis, IN USA
[3] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:64 / 65
页数:2
相关论文
共 50 条
  • [42] Adherence to Antipsychotic Therapy: Association With Hospitalization and Medicare Spending Among Part D Enrollees With Schizophrenia
    Roberto, Pamela
    Brandt, Nicole
    Onukwugha, Eberechukwu
    Perfetto, Eleanor
    Powers, Christopher
    Stuart, Bruce
    PSYCHIATRIC SERVICES, 2017, 68 (11) : 1185 - 1188
  • [43] Utilization of High-Potency Statin Therapy Following Hospitalization for CHD Among Medicare Beneficiaries
    Rosenson, Robert S.
    Kent, Shia
    Brown, Todd
    Farkouh, Michael
    Levitan, Emily
    Yun, Huifeng
    Sharma, Pradeep
    Safford, Monika
    Kilgore, Meredith
    Muntner, Paul
    Bittner, Vera
    CIRCULATION, 2013, 128 (22)
  • [44] Serum Metabolomics of Schizophrenia Participants by Fasting Insulin Reveals a Broad Metabolic Range Not Associated With Current Atypical Antipsychotic Therapy
    Ward, Kristen
    McHugh, Cora
    Yeomans, Larisa
    Kraal, Zarina
    Flowers, Stephanie
    Karnovsky, Alla
    Ellingrod, Vicki
    Stringer, Kathleen
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S609 - S610
  • [45] Cognitive-behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication - Randomised controlled trial
    Valmaggia, LR
    Van der Gaag, M
    Tarrier, N
    Pijnenborg, M
    Slooff, CJ
    BRITISH JOURNAL OF PSYCHIATRY, 2005, 186 : 324 - 330
  • [46] A comparison of treatment patterns, healthcare resource utilization, and costs among young adult Medicaid beneficiaries with schizophrenia treated with paliperidone palmitate or oral atypical antipsychotics in the US
    Manjelievskaia, Janna
    Amos, Tony B.
    El Khoury, Antoine C.
    Vlahiotis, Anna
    Cole, Ashley
    Juneau, Paul
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (12) : 1221 - 1229
  • [47] Factors associated with 30-day readmissions following medical hospitalizations among Medicaid beneficiaries with schizophrenia, bipolar disorder, and major depressive disorder
    Cook, Judith A.
    Burke-Miller, Jane K.
    Jonikas, Jessica A.
    Aranda, Frances
    Santos, Alberto
    PSYCHIATRY RESEARCH, 2020, 291
  • [48] Prevalence and Correlates of Cigarette Smoking among Chinese Schizophrenia Inpatients Receiving Antipsychotic Mono-Therapy
    Xu, Yan-Min
    Chen, Hong-Hui
    Li, Fu
    Deng, Fang
    Liu, Xiao-Bo
    Yang, Hai-Chen
    Qi, Li-Guo
    Guo, Jin-Hong
    Liu, Tie-Bang
    PLOS ONE, 2014, 9 (02):
  • [49] Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms
    Stauffer, Virginia L.
    Song, Guochen
    Kinon, Bruce J.
    Ascher-Svanum, Haya
    Chen, Lei
    Feldman, Peter D.
    Conley, Robert R.
    SCHIZOPHRENIA RESEARCH, 2012, 134 (2-3) : 195 - 201
  • [50] Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy
    Lipkovich, Ilya A.
    Deberdt, Walter
    Csernansky, John G.
    Sabbe, Bernard
    Keefe, Richard S. E.
    Kollack-Walker, Sara
    BMC PSYCHIATRY, 2009, 9